AI-based explainable diagnostics for Diabetic Retinopathy!
Ophthalytics is an applied Artificial Intelligence-based medical diagnostics company and a world leader in "Explainable AI-Diagnostics". We show you the "why" in AI-based diagnostics! Our revolutionary product, Ophthal-360®, is currently used in multiple hospitals across Asia for diabetic retinopathy detection. In the USA, our platform is available for investigational usage only.
Clearview-360 is a cloud-based software platform, offering cutting-edge AI-based DR detection using ANY fundus camera, along with explainable diagnostics showing you the "why" for determining the diagnosis.
Ophthalytics® is a research & development platform for multiple disease pipelines, including but not limited to the following:
- Diabetic Retinopathy (DR) and Diabetic Macular Edema (DME)
- Age-related Macular Disease (AMD)
- Glaucoma
- Retinopathy of Prematurity (ROP)
- Stroke Risk
- Cardiovascular Risk
At Ophthalytics, we believe in open collaboration and provide a platform for clinicians, educators, researchers, and AI experts to drive the future of AI in ophthalmology. Come and join us!
Brands: Ophthal-360® provides AI-based Diabetic Retinopathy detection using a variety of hardware camera platforms.
Clearview-360 is a cloud-based AI offering for DR detection using ANY camera